(Q84617448)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20671052%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Comparative validation of the SP6 antibody to Ki67 in breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20671052%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Lila Zabaglo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20671052%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Janine Salter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20671052%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Helen Anderson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20671052%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Emma Quinn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20671052%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Margaret Hills

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20671052%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Simone Detre

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20671052%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Roger A'Hern

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20671052%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Mitch Dowsett

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20671052%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20671052

13 June 2024

publication date

29 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20671052%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

8 February 2020

http://jcp.bmjjournals.com/cgi/content/abstract/63/9/800

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20671052

https://syndication.highwire.org/content/doi/10.1136/jcp.2010.077578

13 June 2024

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Journal of Clinical Pathology

13 June 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20671052%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20671052%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20671052%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

800-804

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20671052%20AND%20SRC:MED&resulttype=core&format=json

Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value

8 February 2020

cites work

2

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas

13 June 2024

3

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer

13 June 2024

4

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Proliferation marker MIB-1 correlates well with proliferative activity evaluated by BrdU in breast cancer: an immunohistochemical study including correlation with PCNA, p53, c-erbB-2 and estrogen receptor status

13 June 2024

5

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Relationship between labeling indices of Ki-67 and BrdUrd in human malignant tumors

13 June 2024

6

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Alterations of circadian rhythmicity and sleep in aging: endocrine consequences

13 June 2024

7

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Prognostic value of proliferation in invasive breast cancer: a review

13 June 2024

8

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Proliferation marker Ki-67 in early breast cancer

13 June 2024

9

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients

13 June 2024

10

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer

13 June 2024

11

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.

13 June 2024

13

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1/2 expression status

13 June 2024

15

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics

13 June 2024

16

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer

13 June 2024

17

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Early changes in apoptosis and proliferation following primary chemotherapy for breast cancer

13 June 2024

19

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer

13 June 2024

20

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections

13 June 2024

21

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Cetuximab-based immunotherapy and radioimmunotherapy of head and neck squamous cell carcinoma

13 June 2024

23

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

13 June 2024

24

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Biomarker investigations from the ATAC trial: the role of TA01.

13 June 2024

25

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

A phase II placebo-controlled trial of neoadjuvant anastrozole alone or with gefitinib in early breast cancer

13 June 2024

26

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Cell membrane and cytoplasmic staining for MIB-1 in hyalinizing trabecular adenoma of the thyroid gland

13 June 2024

27

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Sclerosing haemangioma of the lung is positive for MIB-1 in cell membrane and cytoplasmic staining pattern

13 June 2024

28

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Cell membrane expression of MIB-1 in salivary gland pleomorphic adenoma

13 June 2024

29

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Cell membrane reactivity of MIB-1 antibody to Ki67 in human tumors: fact or artifact?

13 June 2024

30

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma.

13 June 2024

31

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists

13 June 2024

32

1 reference

https://api.crossref.org/works/10.1136/JCP.2010.077578

13 June 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20671052%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference